Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S8 from The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading
  1. Home
  2. Publications
  3. Supplementary Figure S8 from The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Supplementary Figure S8 from The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Authors:
  • NSNiranjan Sudhakar
    Niranjan Sudhakar
  • LYLarry Yan
    Larry Yan
  • FQFadia Qiryaqos
    Fadia Qiryaqos
  • LELars D. Engstrom
    Lars D. Engstrom
  • JLJade Laguer
    Jade Laguer
  • ACAndrew Calinisan
    Andrew Calinisan
  • AHAllan Hebbert
    Allan Hebbert
  • LWLaura Waters
    Laura Waters
  • KMKrystal Moya
    Krystal Moya
  • VBVickie Bowcut
    Vickie Bowcut
  • LVLaura Vegar
    Laura Vegar
  • JKJohn M. Ketcham
    John M. Ketcham

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32712964
Abstract
Supplementary Figure S8 details the antitumor effects associated with coadministration of MRTX0902 and adagrasib in the MIA PaCa-2 (KRAS G12C-mutant) model.
Keywords
  • SUPPLEMENTARY FIGURE
  • CANCERS DEPENDENT
  • NUCLEOTIDE LOADING
  • BLOCKS KRAS
  • LOADING SUPPLEMENTARY
  • KRAS ACTIVATION
  • KRAS NUCLEOTIDE
  • DEMONSTRATES ANTITUMOR
  • ANTITUMOR ACTIVITY
  • ANTITUMOR EFFECTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.